Vimarsana
Biggest News Aggregation in the World

Page 10 - Grant Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grant Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grant Date Today - Breaking & Trending Today

Volution : 2023 Deferred Share Bonus Plan Rules -October 19, 2023 at 07:45 am EDT - Vimarsana News

Volution : 2023 Deferred Share Bonus Plan Rules -October 19, 2023 at 07:45 am EDT

Rules of the Volution Group plc 2023 Deferred Share Bonus Plan Adopted by the Board on [•] 2023 Approved by shareholders on [•] 2023 ...

Dunelm : Long Term Incentive Plan Rules (relating to AGM resolution) -October 19, 2023 at 05:03 am EDT - Vimarsana News

Dunelm : Long Term Incentive Plan Rules (relating to AGM resolution) -October 19, 2023 at 05:03 am EDT

Rules of the Dunelm Group 2014 Long Term Incentive Plan Approved by the shareholders of Dunelm Group plc on 11 November 2014 ...

Rockwell Medical Names Jesse Neri as Senior Vice President, Finance - Vimarsana News

Rockwell Medical Names Jesse Neri as Senior Vice President, Finance

Rockwell Medical, Inc. , a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that...

McBride : 2020 Restricted Share Unit Plan Amendments for approval at 2023 AGM -October 17, 2023 at 11:39 am EDT - Vimarsana News

McBride : 2020 Restricted Share Unit Plan Amendments for approval at 2023 AGM -October 17, 2023 at 11:39 am EDT

MCBRIDE PLC THE MCBRIDE PLC 2020 RESTRICTED SHARE UNIT PLAN Approved by shareholders of the Company on 23 November...

Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4) - Vimarsana News

Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...